{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T21:25:36Z","timestamp":1790371536315,"version":"4.1.0"},"reference-count":78,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003329","name":"Ministry of Economy and Competitiveness","doi-asserted-by":"publisher","award":["SAF-2014-53040-P"],"award-info":[{"award-number":["SAF-2014-53040-P"]}],"id":[{"id":"10.13039\/501100003329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Neurology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.expneurol.2018.08.007","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T16:58:58Z","timestamp":1534784338000},"page":"14-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"special_numbering":"C","title":["Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway"],"prefix":"10.1016","volume":"310","author":[{"given":"Juan Ram\u00f3n","family":"Perea","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"\u00c1vila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Bol\u00f3s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.expneurol.2018.08.007_bb0005","doi-asserted-by":"crossref","first-page":"9677","DOI":"10.1523\/JNEUROSCI.4742-11.2012","article-title":"An effector-reduced anti-beta-amyloid (Abeta) antibody with unique abeta binding properties promotes neuroprotection and glial engulfment of Abeta","volume":"32","author":"Adolfsson","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0010","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/glia.1106","article-title":"Immune function of microglia","volume":"36","author":"Aloisi","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0015","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/j.jalz.2015.12.014","article-title":"Molecular mechanism of prion-like tau-induced neurodegeneration","volume":"12","author":"Alonso","year":"2016","journal-title":"Alzheimers Dement."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0020","doi-asserted-by":"crossref","first-page":"5446","DOI":"10.1523\/JNEUROSCI.4637-04.2005","article-title":"Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms","volume":"25","author":"Andorfer","year":"2005","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0025","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nri3495","article-title":"Mitogen-activated protein kinases in innate immunity","volume":"13","author":"Arthur","year":"2013","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.3389\/fnagi.2016.00262","article-title":"Tau structures","volume":"8","author":"Avila","year":"2016","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0035","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1742-2094-8-79","article-title":"Microglial p38alpha MAPK is a key regulator of proinflammatory cytokine up-regulation induced by toll-like receptor (TLR) ligands or beta-amyloid (Abeta)","volume":"8","author":"Bachstetter","year":"2011","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0040","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1007\/s11481-014-9543-3","article-title":"Target engagement analysis and link to pharmacodynamic endpoint for a novel class of CNS-penetrant and efficacious p38alpha MAPK inhibitors","volume":"9","author":"Bachstetter","year":"2014","journal-title":"J. NeuroImmune Pharmacol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0045","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1002\/1098-1128(200103)21:2<129::AID-MED1003>3.0.CO;2-H","article-title":"Inhibition of p38 mitogen-activated protein kinase provides neuroprotection in cerebral focal ischemia","volume":"21","author":"Barone","year":"2001","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0050","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S0022-3565(24)38747-6","article-title":"SB 239063, a second-generation p38 mitogen-activated protein kinase inhibitor, reduces brain injury and neurological deficits in cerebral focal ischemia","volume":"296","author":"Barone","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3233\/JAD-150704","article-title":"Direct evidence of internalization of tau by microglia in vitro and in vivo","volume":"50","author":"Bolos","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0060","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13024-017-0200-1","article-title":"Absence of CX3CR1 impairs the internalization of Tau by microglia","volume":"12","author":"Bolos","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0065","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1038\/s41398-017-0013-6","article-title":"Soluble Tau has devastating effects on the structural plasticity of hippocampal granule neurons","volume":"7","author":"Bolos","year":"2017","journal-title":"Transl. Psychiatry"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0070","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1515\/bmc-2016-0029","article-title":"Alzheimer's disease as an inflammatory disease","volume":"8","author":"Bolos","year":"2017","journal-title":"Biomol. Concepts"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0075","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.bbi.2017.10.002","article-title":"Absence of microglial CX3CR1 impairs the synaptic integration of adult-born hippocampal granule neurons","volume":"68","author":"Bolos","year":"2018","journal-title":"Brain Behav. Immun."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0080","doi-asserted-by":"crossref","first-page":"824","DOI":"10.4161\/cc.5.8.2685","article-title":"p38 MAPK in development and cancer","volume":"5","author":"Bradham","year":"2006","journal-title":"Cell Cycle"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0085","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s004010050978","article-title":"Phosphorylated serine422 on tau proteins is a pathological epitope found in several diseases with neurofibrillary degeneration","volume":"97","author":"Bussiere","year":"1999","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0090","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/343461a0","article-title":"Inhibition of neurite polarity by tau antisense oligonucleotides in primary cerebellar neurons","volume":"343","author":"Caceres","year":"1990","journal-title":"Nature"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0095","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/649079","article-title":"The role of p38 MAPK and its substrates in neuronal plasticity and neurodegenerative disease","volume":"2012","author":"Correa","year":"2012","journal-title":"J. Signal. Transduct."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.3389\/fneur.2013.00114","article-title":"Are tau aggregates toxic or protective in tauopathies?","volume":"4","author":"Cowan","year":"2013","journal-title":"Front. Neurol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0105","doi-asserted-by":"crossref","first-page":"23658","DOI":"10.1074\/jbc.M513646200","article-title":"MAPK-activated protein kinase 2 deficiency in microglia inhibits pro-inflammatory mediator release and resultant neurotoxicity. Relevance to neuroinflammation in a transgenic mouse model of Alzheimer disease","volume":"281","author":"Culbert","year":"2006","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0110","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.nbd.2006.12.023","article-title":"Inhibition of p38 mitogen activated protein kinase activation and mutant SOD1(G93A)-induced motor neuron death","volume":"26","author":"Dewil","year":"2007","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0115","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.4103\/1673-5374.193220","article-title":"Clearing the corpses: regulatory mechanisms, novel tools, and therapeutic potential of harnessing microglial phagocytosis in the diseased brain","volume":"11","author":"Diaz-Aparicio","year":"2016","journal-title":"Neural Regen. Res."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0120","doi-asserted-by":"crossref","first-page":"32539","DOI":"10.1074\/jbc.M110.145003","article-title":"Tissue-nonspecific alkaline phosphatase promotes the neurotoxicity effect of extracellular tau","volume":"285","author":"Diaz-Hernandez","year":"2010","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0125","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1007\/978-94-017-7197-9_18","article-title":"TNAP plays a key role in neural differentiation as well as in neurodegenerative disorders","volume":"76","author":"Diaz-Hernandez","year":"2015","journal-title":"Subcell. Biochem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0130","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1083\/jcb.103.6.2739","article-title":"Tau protein function in living cells","volume":"103","author":"Drubin","year":"1986","journal-title":"J. Cell Biol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0135","doi-asserted-by":"crossref","DOI":"10.1038\/srep19393","article-title":"Extracellular tau oligomers produce an immediate impairment of LTP and memory","volume":"6","author":"Fa","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0140","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1097\/NEN.0b013e318220a658","article-title":"Soluble tau species, not neurofibrillary aggregates, disrupt neural system integration in a tau transgenic model","volume":"70","author":"Fox","year":"2011","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0145","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1021\/cn500143n","article-title":"Advances in therapeutics for neurodegenerative tauopathies: moving toward the specific targeting of the most toxic tau species","volume":"5","author":"Gerson","year":"2014","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0150","doi-asserted-by":"crossref","first-page":"13750","DOI":"10.1523\/JNEUROSCI.2998-10.2010","article-title":"Mitogen-activated protein kinase-activated protein kinase 2 (MK2) contributes to secondary damage after spinal cord injury","volume":"30","author":"Ghasemlou","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0155","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.brainres.2004.01.071","article-title":"Expression of an altered form of tau in Sf9 insect cells results in the assembly of polymers resembling Alzheimer's paired helical filaments","volume":"1007","author":"Gomez-Ramos","year":"2004","journal-title":"Brain Res."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0160","doi-asserted-by":"crossref","first-page":"4842","DOI":"10.1016\/j.febslet.2006.07.078","article-title":"Extracellular tau is toxic to neuronal cells","volume":"580","author":"Gomez-Ramos","year":"2006","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0165","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1146\/annurev.neuro.22.1.219","article-title":"Microglia as mediators of inflammatory and degenerative diseases","volume":"22","author":"Gonzalez-Scarano","year":"1999","journal-title":"Annu. Rev. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0170","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0175","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/nrm2101","article-title":"Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide","volume":"8","author":"Haass","year":"2007","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0180","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1002\/glia.10161","article-title":"Microglia as a source and target of cytokines","volume":"40","author":"Hanisch","year":"2002","journal-title":"Glia"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0185","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0014-5793(96)00271-2","article-title":"Characterization of mAb AP422, a novel phosphorylation-dependent monoclonal antibody against tau protein","volume":"384","author":"Hasegawa","year":"1996","journal-title":"FEBS Lett."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0190","doi-asserted-by":"crossref","first-page":"8114","DOI":"10.1021\/bi970380+","article-title":"Unique Alzheimer's disease paired helical filament specific epitopes involve double phosphorylation at specific sites","volume":"36","author":"Hoffmann","year":"1997","journal-title":"Biochemistry"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0195","doi-asserted-by":"crossref","first-page":"19855","DOI":"10.1074\/jbc.R114.549295","article-title":"Prion-like properties of Tau protein: the importance of extracellular Tau as a therapeutic target","volume":"289","author":"Holmes","year":"2014","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0200","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/j.neuron.2014.06.004","article-title":"Tau propagation, different tau phenotypes, and prion-like properties of tau","volume":"82","author":"Hyman","year":"2014","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0205","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/S0896-6273(00)81127-7","article-title":"Age-dependent emergence and progression of a tauopathy in transgenic mice overexpressing the shortest human tau isoform","volume":"24","author":"Ishihara","year":"1999","journal-title":"Neuron"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0210","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0002-9440(10)63997-1","article-title":"Age-dependent induction of congophilic neurofibrillary tau inclusions in tau transgenic mice","volume":"158","author":"Ishihara","year":"2001","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0215","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1471-4159.1997.69052087.x","article-title":"A conformation- and phosphorylation-dependent antibody recognizing the paired helical filaments of Alzheimer's disease","volume":"69","author":"Jicha","year":"1997","journal-title":"J. Neurochem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0220","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/0166-2236(96)10049-7","article-title":"Microglia: a sensor for pathological events in the CNS","volume":"19","author":"Kreutzberg","year":"1996","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0225","doi-asserted-by":"crossref","first-page":"9673","DOI":"10.1073\/pnas.0602913103","article-title":"An inhibitor of tau hyperphosphorylation prevents severe motor impairments in tau transgenic mice","volume":"103","author":"Le Corre","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0230","doi-asserted-by":"crossref","DOI":"10.3390\/molecules22081287","article-title":"Recent advances in the inhibition of p38 MAPK as a potential strategy for the treatment of Alzheimer's disease","volume":"22","author":"Lee","year":"2017","journal-title":"Molecules"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0235","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s13024-017-0192-x","article-title":"Glial contributions to neurodegeneration in tauopathies","volume":"12","author":"Leyns","year":"2017","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0240","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1093\/brain\/awv081","article-title":"Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain","volume":"138","author":"Maphis","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0245","doi-asserted-by":"crossref","first-page":"4451","DOI":"10.1523\/JNEUROSCI.18-12-04451.1998","article-title":"Beta-Amyloid fibrils activate parallel mitogen-activated protein kinase pathways in microglia and THP1 monocytes","volume":"18","author":"McDonald","year":"1998","journal-title":"J. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0250","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1212\/WNL.47.2.425","article-title":"Arthritis and anti-inflammatory agents as possible protective factors for Alzheimer's disease: a review of 17 epidemiologic studies","volume":"47","author":"McGeer","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0255","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.3233\/JAD-140755","article-title":"Is tau a prion-like protein?","volume":"40","author":"Medina","year":"2014","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0260","doi-asserted-by":"crossref","first-page":"113","DOI":"10.3389\/fncel.2014.00113","article-title":"The role of extracellular Tau in the spreading of neurofibrillary pathology","volume":"8","author":"Medina","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0265","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/BF00929506","article-title":"The role of tau phosphorylation in transfected COS-1 cells","volume":"148","author":"Medina","year":"1995","journal-title":"Mol. Cell. Biochem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0270","article-title":"New features about tau function and dysfunction","volume":"6","author":"Medina","year":"2016","journal-title":"Biomol. Ther."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0275","doi-asserted-by":"crossref","first-page":"14893","DOI":"10.1074\/jbc.M115.652693","article-title":"Tau trimers are the minimal propagation unit spontaneously internalized to seed intracellular aggregation","volume":"290","author":"Mirbaha","year":"2015","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0280","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1742-2094-4-21","article-title":"A novel p38 alpha MAPK inhibitor suppresses brain proinflammatory cytokine up-regulation and attenuates synaptic dysfunction and behavioral deficits in an Alzheimer's disease mouse model","volume":"4","author":"Munoz","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0285","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/0304-3940(95)11595-N","article-title":"Investigation of tau-2 positive microglia-like cells in the subcortical nuclei of human neurodegenerative disorders","volume":"192","author":"Odawara","year":"1995","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0290","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neulet.2016.09.026","article-title":"Secretion of full-length tau or tau fragments in a cell culture model","volume":"634","author":"Perez","year":"2016","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0295","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1002\/jnr.10671","article-title":"Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult","volume":"73","author":"Piao","year":"2003","journal-title":"J. Neurosci. Res."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0300","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1126\/science.aag2590","article-title":"How neuroinflammation contributes to neurodegeneration","volume":"353","author":"Ransohoff","year":"2016","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0305","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a020560","article-title":"Microglia in health and disease","volume":"8","author":"Ransohoff","year":"2016","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0310","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/acschemneuro.5b00002","article-title":"Targeting human central nervous system protein kinases: an isoform selective p38alphaMAPK inhibitor that attenuates disease progression in Alzheimer's disease mouse models","volume":"6","author":"Roy","year":"2015","journal-title":"ACS Chem. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0315","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/acn3.549","article-title":"An exploratory clinical study of p38alpha kinase inhibition in Alzheimer's disease","volume":"5","author":"Scheltens","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0320","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1126\/science.6120571","article-title":"Alzheimer's disease: insolubility of partially purified paired helical filaments in sodium dodecyl sulfate and urea","volume":"215","author":"Selkoe","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0325","doi-asserted-by":"crossref","first-page":"240","DOI":"10.3389\/fncel.2014.00240","article-title":"Never-resting microglia: physiological roles in the healthy brain and pathological implications","volume":"8","author":"Sierra","year":"2014","journal-title":"Front. Cell. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0330","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.tins.2008.11.007","article-title":"Tau pathophysiology in neurodegeneration: a tangled issue","volume":"32","author":"Spires-Jones","year":"2009","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0335","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0014-4886(03)00180-8","article-title":"P38 MAP kinase is activated at early stages in Alzheimer's disease brain","volume":"183","author":"Sun","year":"2003","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0340","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/0022-510X(70)90063-8","article-title":"Observations on the brains of demented old people","volume":"11","author":"Tomlinson","year":"1970","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0345","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1016\/j.celrep.2017.07.082","article-title":"The deacetylase HDAC6 mediates endogenous neuritic tau pathology","volume":"20","author":"Tseng","year":"2017","journal-title":"Cell Rep."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0350","first-page":"L895","article-title":"SB 239063, a p38 MAPK inhibitor, reduces neutrophilia, inflammatory cytokines, MMP-9, and fibrosis in lung","volume":"279","author":"Underwood","year":"2000","journal-title":"Am. J. Phys. Lung Cell. Mol. Phys."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0355","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.jocn.2013.08.017","article-title":"Peripheral expression of MAPK pathways in Alzheimer's and Parkinson's diseases","volume":"21","author":"Wang","year":"2014","journal-title":"J. Clin. Neurosci."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0360","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066226","article-title":"Development of novel in vivo chemical probes to address CNS protein kinase involvement in synaptic dysfunction","volume":"8","author":"Watterson","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0365","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1126\/science.7058341","article-title":"Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain","volume":"215","author":"Whitehouse","year":"1982","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0370","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1126\/science.1062382","article-title":"Tauopathy in Drosophila: neurodegeneration without neurofibrillary tangles","volume":"293","author":"Wittmann","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.expneurol.2018.08.007_bb0375","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/1750-1326-6-84","article-title":"Microglial p38alpha MAPK is critical for LPS-induced neuron degeneration, through a mechanism involving TNFalpha","volume":"6","author":"Xing","year":"2011","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0380","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1084\/jem.20131685","article-title":"Neuronal activity regulates extracellular Tau in vivo","volume":"211","author":"Yamada","year":"2014","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0385","doi-asserted-by":"crossref","first-page":"12116","DOI":"10.1074\/jbc.272.18.12116","article-title":"Pyridinyl imidazole inhibitors of p38 mitogen-activated protein kinase bind in the ATP site","volume":"272","author":"Young","year":"1997","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.expneurol.2018.08.007_bb0390","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1159\/000067426","article-title":"The role of mitogen-activated protein kinase pathways in Alzheimer's disease","volume":"11","author":"Zhu","year":"2002","journal-title":"Neurosignals"}],"container-title":["Experimental Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618303534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014488618303534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T12:34:58Z","timestamp":1751805298000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014488618303534"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":78,"alternative-id":["S0014488618303534"],"URL":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.08.007","relation":{},"ISSN":["0014-4886"],"issn-type":[{"value":"0014-4886","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dephosphorylated rather than hyperphosphorylated Tau triggers a pro-inflammatory profile in microglia through the p38 MAPK pathway","name":"articletitle","label":"Article Title"},{"value":"Experimental Neurology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.expneurol.2018.08.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}